Long-term follow-up of pancreatic cysts that resolve radiologically after EUS-guided ethanol ablation
Background EUS-guided ablation of pancreatic cysts is a minimally invasive technique with reported short-term, CT-defined cyst resolution rates of 33% to 79%. Follow-up results of image-defined, successful pancreatic cyst ablation are not known. Objective To determine the durability of successful cy...
Saved in:
Published in | Gastrointestinal endoscopy Vol. 72; no. 4; pp. 862 - 866 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Maryland heights, MO
Mosby, Inc
01.10.2010
Elsevier |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Background EUS-guided ablation of pancreatic cysts is a minimally invasive technique with reported short-term, CT-defined cyst resolution rates of 33% to 79%. Follow-up results of image-defined, successful pancreatic cyst ablation are not known. Objective To determine the durability of successful cyst resolution after EUS-guided ethanol lavage. Design Prospective cohort study. Setting Two tertiary-care referral hospitals in the United States. Patients This study involved 12 patients with 1-to-5-cm, unilocular, pancreatic cysts that had previously resolved after ethanol lavage. Interventions Follow-up CT after cyst resolution. Main Outcome Measurements The presence or absence of residual pancreatic cysts by CT scanning after previous successful ablation. Results In a previously reported trial, we found that CT scanning documented pancreatic cyst resolution in 12 patients (33%) after one (n = 6) or two (n = 6) ethanol lavages. These 12 cysts (median diameter 18 mm; range 10-34 mm) were located in the head/uncinate of the pancreas in 6 patients (50%) and in the body of the pancreas in 6 patients (50%). The median cyst fluid carcinoembryonic antigen (CEA) level (available in 11 patients) was 463 ng/mL (range 1.6-64,550 ng/mL; normal, 0-2.5 ng/mL). Clinical diagnoses were mucinous cystic neoplasm (MCN) in 9 patients, intraductal papillary mucinous neoplasm in 1 patient, pseudocyst in 1 patient, and serous cystadenoma (SCA) in 1 patient. Follow-up CT in 3 patients (one each of MCN, SCA, and pseudocyst) after the initial diagnosis of cyst resolution was not available. For the remaining 9 patients (75%), follow-up CT performed in a median of 26 months (range 13-39 months) after initial documentation of cyst resolution demonstrated no evidence of cyst recurrence in any patient. Limitations Loss to follow-up of some of the cohort. Conclusions Follow-up after successful EUS-guided ethanol ablation of pancreatic cysts, including suspected mucinous cysts, suggests a durable, image-defined resolution. Longer follow-up in these patients is needed before considering these patients “cured” of their disease. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-News-2 ObjectType-Feature-3 content type line 23 |
ISSN: | 0016-5107 1097-6779 |
DOI: | 10.1016/j.gie.2010.02.039 |